S&S Healthcare Holding Ltd. carries a market capitalization of 1.01B, placing it among publicly traded companies globally. Its enterprise value stands at 848.32M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.01B |
| Enterprise Value | 848.32M |
S&S Healthcare Holding Ltd. currently has 24.11M shares outstanding.
| Shares Outstanding | 24.11M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 4.29, and the price-to-book ratio stands at 5.19.
| PE Ratio | N/A |
| PS Ratio | 4.29 |
| PB Ratio | 5.19 |
| P/TBV Ratio | 3.49 |
| P/FCF Ratio | -36.32 |
| P/OCF Ratio | -32.88 |
| EV / Sales | 4.15 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 179.49 |
S&S Healthcare Holding Ltd. maintains a current ratio of 2.93, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.28, indicating elevated leverage, while an interest coverage ratio of -45.90 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.93 |
| Quick Ratio | 1.19 |
| Debt / Equity | 10.28 |
| Debt / EBITDA | -0.60 |
| Interest Coverage | -45.90 |
| Return on Equity (ROE) | -24.66 |
| Return on Assets (ROA) | -11.66 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.01 |
| Income Tax | -510,000.00 |
| Effective Tax Rate | N/A |
S&S Healthcare Holding Ltd.'s stock has declined approximately -0.47619048% over the past 52 weeks. The 50-day moving average sits at 38.31, while the 200-day moving average is 37.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.47619048% |
| 50-Day Moving Average | 38.31 |
| 200-Day Moving Average | 37.31 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, S&S Healthcare Holding Ltd. generated 204.21M in revenue and converted that into -47.29M in net income, yielding earnings per share of -2.00. EBITDA reached -47.23M, while operating income came in at -47.23M.
| Revenue | 204.21M |
| Gross Profit | 67.11M |
| Operating Income | -47.23M |
| Pretax Income | -48.45M |
| Net Income | -47.29M |
| EBITDA | -47.23M |
| EBIT | -47.23M |
| Earnings Per Share (EPS) | -2.00 |
S&S Healthcare Holding Ltd. holds 106.85M in cash and equivalents against 28.44M in total debt, resulting in a net debt position of -89.73M. Total book value stands at 168.96M, with working capital of 173.09M providing operational flexibility.
| Cash & Cash Equivalents | 106.85M |
| Total Debt | 28.44M |
| Net Debt | -89.73M |
| Equity (Book Value) | 168.96M |
| Book Value Per Share | 7.04 |
| Working Capital | 173.09M |
S&S Healthcare Holding Ltd. produced -26.66M in operating cash flow over the past twelve months. After subtracting -2.52M in capital expenditures, free cash flow totaled -29.18M - equivalent to -1.22 per share.
| Operating Cash Flow | -26.66M |
| Capital Expenditures | -2.52M |
| Free Cash Flow | -29.18M |
| FCF Per Share | -1.22 |
S&S Healthcare Holding Ltd. operates with a gross margin of 32.86, reflecting its pricing power and cost economics. The operating margin of -23.13 and net profit margin of -23.16 provide insight into operational efficiency.
| Gross Margin | 32.86 |
| Operating Margin | -23.13 |
| Pretax Margin | -23.73 |
| Profit Margin | -23.16 |
| EBITDA Margin | -23.13 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.51 |
| FCF Yield | -2.75 |
S&S Healthcare Holding Ltd.'s most recent stock split took place on August 4, 2022 with a 5:1 split ratio.
| Last Split Date | 8/4/2022 |
| Split Ratio | 5:1 |
S&S Healthcare Holding Ltd. posts an Altman Z-Score of 5.68, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.68 |